These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25711510)

  • 21. Case series on aripiprazole and dopamine supersensitivity psychosis.
    Russell G; Reinfeld S; Kam O; Lee G; Weiss M; Koola MM
    Int Clin Psychopharmacol; 2022 May; 37(3):122-128. PubMed ID: 35143441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study.
    Lodhi RJ; Masand S; Malik A; Shivakumar K; McAllister VD; O'Keane V; Young LC; Heald AH; Sherwood RA; Aitchison KJ
    Schizophr Res; 2016 Feb; 170(2-3):245-51. PubMed ID: 26792297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of aripiprazole-induced tardive Pisa syndrome: a case report and literature review.
    De Risio L; Pettorruso M; Di Nicola M; Martinotti G; Janiri L; Fasano A
    Int Clin Psychopharmacol; 2016 Jan; 31(1):57-60. PubMed ID: 26426442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of Prolactin Concentrations to Steady-State Plasma Concentrations of Aripiprazole in Patients With Schizophrenia.
    Tasaki M; Yasui-Furukori N; Kubo K; Yokoyama S; Shinozaki M; Sugawara N; Inoue Y; Shimoda K
    Ther Drug Monit; 2021 Aug; 43(4):589-592. PubMed ID: 33235024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
    Jakobsen KD; Bruhn CH; Pagsberg AK; Fink-Jensen A; Nielsen J
    J Clin Psychopharmacol; 2016 Oct; 36(5):496-9. PubMed ID: 27504593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of aripiprazole for delirium in the elderly: a short review.
    Kirino E
    Psychogeriatrics; 2015 Mar; 15(1):75-84. PubMed ID: 25514894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysis.
    Labad J; Montalvo I; González-Rodríguez A; García-Rizo C; Crespo-Facorro B; Monreal JA; Palao D
    Schizophr Res; 2020 Aug; 222():88-96. PubMed ID: 32507371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder.
    Kim CY; Chung S; Lee JN; Kwon JS; Kim DH; Kim CE; Jeong B; Jeon YW; Lee MS; Jun TY; Jung HY
    Int Clin Psychopharmacol; 2009 Jul; 24(4):181-8. PubMed ID: 19451828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aripiprazole as dopamine partial agonist model: Basic concepts and clinical impact].
    Simon N; Azorin JM
    Encephale; 2018 Dec; 44(6):558-564. PubMed ID: 30466778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aripiprazole induced Impulse Control Disorders: Where do we stand?
    Mahapatra A; Sharma P; Sagar R
    Asian J Psychiatr; 2016 Oct; 23():128-130. PubMed ID: 27969070
    [No Abstract]   [Full Text] [Related]  

  • 33. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
    Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR
    Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of NTRK2, DRD2 and ACE polymorphisms on prolactin levels in antipsychotic-treated patients with first-episode psychosis.
    Gassó P; Mas S; Bioque M; Cabrera B; Lobo A; González-Pinto A; Díaz-Caneja CM; Corripio I; Vieta E; Castro-Fornieles J; Sarró S; Mané A; Sanjuan J; Llerena A; Lafuente A; Saiz-Ruiz J; Bernardo M;
    J Psychopharmacol; 2018 Jun; 32(6):702-710. PubMed ID: 29767567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
    Chen CK; Huang YS; Ree SC; Hsiao CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aripiprazole use in children and adolescent psychiatric patients].
    Chevreuil C; Polard E; Lemonnier E; Guillemot P; Bentué-Ferrer D;
    Therapie; 2011; 66(2):123-30. PubMed ID: 21635859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
    Letmaier M; Painold A; Holl AK; Grohmann R; Vergin H
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):153-6. PubMed ID: 22211772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aripiprazole induced Parkinsonism: A case report].
    Pasquier de Franclieu S; Germain C; Petitjean F
    Encephale; 2009 Oct; 35(5):496-8. PubMed ID: 19853725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central sleep apnea in a geriatric patient treated with aripiprazole.
    Kohen I; Sarcevic A
    Am J Ther; 2009; 16(2):197-8. PubMed ID: 19300045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.